The global peptide synthesis market size is expected to reach USD 1,011.99 million by 2026 growing at a CAGR of 13.0%, according to a new report by Grand View Research, Inc. Significant research and innovation targeted towards the development of peptide therapeutics is set to boost the market growth in the near future. Additionally, increasing advancements in the peptide synthesis technologies is expected to offer profitable opportunities for the companies operating in the market.
A
surge in the demand for custom peptide synthesis has been observed in the
recent years; several companies operating in this industry offer products and
services associated with custom peptide synthesis. For instance, a UK based
company namely, Almac Group offers peptide synthesis suitable for research use.
Constantly growing demand and evolving market landscape for custom peptides is
set to offer lucrative opportunities for the market growth. The suppliers are
expanding their production capacity to suffice the increasing demand for high
quality peptides across research and therapeutics areas.
Rising
focus of the pharmaceutical companies towards the development of novel
biologics and shifting the peptide drugs from the pipeline stage to commercial
scale further strengthens the market growth. Increase in the number of research
activities performed on exploring the potential of high-quality peptides and
peptide libraries in the development of vaccines and biomarker discovery
heavily contributes to the revenue generated by the global peptide synthesis
market. Moreover, introduction of modified peptides (GMP peptides) that possess
enhanced stability and pharmacokinetic properties in the market is expected to
maintain the double-digit market growth throughout the forecast period.
Therapeutic
peptide development has witnessed remarkable growth in the recent years, this
is further driven by significant increase in the patient pool suffering from
cardiovascular and metabolic diseases. This has propelled the discovery of
bioactive peptides exponentially which further drives the market demand.
Full Research Report On Peptide Synthesis Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market
Further key
findings from the study suggest:
- Reagents & consumables accounted for the
highest revenue generated in 2018 and is anticipated to maintain this
trend throughout the forecast period.
- Peptide synthesis equipment has registered
fastest growth during the forecast period.
- Peptide synthesizers segment serves to be a major
contributor to the revenue generated by equipment in the global market and
is anticipated to grow at highest CAGR of 13.91% from 2019-2026 among
other peptide synthesis equipment.
- Liquid phase peptide synthesis (LPPS) technology
dominated the peptide synthesis market in 2018 and is expected to continue
this dominance throughout the forecast period.
- Therapeutic peptide synthesis has garnered
largest share in the market in 2018 and is anticipated to maintain this
trend throughout the forecast period.
- North America region has generated highest
revenue in 2018 and is expected to maintain this dominance throughout the
forecast period; sufficient presence of skilled professionals along with
the strong network of peptide synthesis manufacturers is attributive to
this region’s dominance in the global market.
- APAC is expected to offer lucrative opportunities
for the market expansion, attributed to rising focus on the development of
peptide therapeutics.
- Large patient pool for cardiovascular and
metabolic diseases in the APAC region has significantly contributed to the
revenue generated, contributing to the highest CAGR registered during the
forecast period.
- Some of the key market participants are Genscript
Biotech, Merck KGaA, Bachem Holdings, Biotage, CEM Corporation, Thermo
Fisher, and Novo Nordisk among others.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/peptide-synthesis-market/request/rs1
Grand View Research has
segmented the global peptide synthesis market on the basis of product,
technology, application, end-use, and region:
Peptide Synthesis
Product Outlook (Revenue, USD Million, 2014 - 2026)
- Equipment
- Peptide Synthesizers
- Lyophilizers
- Chromatography Equipment
- Others
- Reagents & Consumables
- Other
Peptide Synthesis
Technology Outlook (Revenue, USD Million, 2014 - 2026)
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
Peptide Synthesis
Application Outlook (Revenue, USD Million, 2014 - 2026)
- Therapeutics
- Cancer
- Metabolic
- Cardiovascular Disorder
- Respiratory
- GIT (Gastrointestinal Disorders)
- Infectious Diseases
- Pain
- Dermatology
- CNS
- Renal
- Others
- Diagnosis
- Research
Peptide Synthesis
End-use Outlook (Revenue, USD Million, 2014 - 2026)
- Pharmaceutical & Biotechnology Companies
- Contract Development & Manufacturing
Organization/Contract Research Organization
- Academic & Research Institutes
Peptide Synthesis
Regional Outlook (Revenue, USD Million, 2014 - 2026)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Asia Pacific
- Japan
- China
- India
- Australia
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment